Dr. Ingmar Gorman is a co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike. Dr. Gorman received his clinical training in New York City at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University. He simultaneously served as site co-principal investigator on an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and is currently a study therapist on the same study, as well as another FDA approved clinical trial of psilocybin for treatment resistant depression. Dr. Gorman has published on the topics of classic psychedelics, ketamine, MDMA, and Psychedelic Harm Reduction and Integration.
Psychedelic-Assisted Psychotherapy is a technique that involves the use of drugs that produce a psychedelic effect in order to assist in the psychotherapy process. The U.S. Food and Drug Administration (FDA) named psilocybin-assisted therapy as a “breakthrough therapy.” Over the last two decades, researchers have received approval from governmental authorities to conduct trials on the use of the psychedelic substances to treat various conditions. What researchers have found is that psychedelic substances can have beneficial therapeutic effects. According to the research, there are a number of potential applications for psychedelic therapy such as anxiety, depression, substance use, alcohol use, and PTSD. At present, there are multiple clinical trials on psychedelic assisted therapy, some in phase II and III.
TherapyShow.com/Psychedelic-Assisted-Psychotherapy
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Twitter @Fluencetraining
Disclaimer: The information shared in this podcast is not a substitute for getting help from a mental health professional.
#43 Dr. Richard Schwartz on Internal Family Systems and How We Are the 'Sum of Our Parts'
#42 Dr. DuWayne Battle on Diversity & Social Justice in Social Work
#41 Dr. Sue Johnson on Emotionally Focused Therapy for Couples and Individuals
#40 'Drug Dealer M.D.' Author, Dr. Anna Lembke, discusses the latest addiction treatments
#39 Dr Linda Carpenter on Transcranial Magnetic Stimulation 'TMS' a Noninvasive Brain Stimulation Treatment
#38 Dr. Walter Kaye Discusses the Latest in Eating Disorder Treatment
#37 Dr. John Oldham Explains Personality Styles vs Personality Disorders
#36 Dr. Arthur Becker-Weidman discusses Attachment-Focused Therapy for Children & Adolescents
#35 Dr. Husseini Manji Discusses Innovative Treatment for Major Depressive Disorder
#34 Dr. Thomas Insel and Lara Gregorio, LCSW describe NEST Health an Innovative Online Therapy Service
#33 Dr. George Koob on the Neurobiology of Addiction
#32 Dr. John Krystal on the Neurobiology of PTSD
#31 Coping with Grief and Loss During the Covid-19 Pandemic. Dr. Judith McCoyd Interview
#30 How Can ASSYST Remote EMDR Therapy Help During Covid-19 Pandemic? Kelly Smyth-Dent, LCSW Interview
#29 Deb Dana, LCSW Explains Polyvagal Therapy for Safety and Connection
#28 Dr. Michael LaSala Discusses Gay and Lesbian Family Therapy
#27 Dr. Arnold Pallay Explains Pharmacogenetic Testing
#26 Dr. Helen Blair Simpson Discusses the Latest Treatment for Obsessive Compulsive Disorder 'OCD'
#25 Dr. Jesse Wright on Getting Your Life Back Using Cognitive Behavioral Therapy
#24 Dr. Tayyab Rashid Author of 'Positive Psychotherapy' Asks: "What are you good at?"
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Your Sleep Guru Podcast
Anxiety Slayer™ with Shann and Ananga
Men Do Talk Podcast
The Dr. John Delony Show
On Purpose with Jay Shetty